<!DOCTYPE html>
<!--[if lt IE 7 ]> <html lang="en" class="no-js ie6 lt8"> <![endif]-->
<!--[if IE 7 ]>    <html lang="en" class="no-js ie7 lt8"> <![endif]-->
<!--[if IE 8 ]>    <html lang="en" class="no-js ie8 lt8"> <![endif]-->
<!--[if IE 9 ]>    <html lang="en" class="no-js ie9"> <![endif]-->
<!--[if (gt IE 9)|!(IE)]><!-->
<html lang="en">
<!--<![endif]-->

<!-- Mirrored from www.newswise.com/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 11 May 2023 10:23:22 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
<title>First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer</title>

<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="p:domain_verify" content="7efbfb16591069f62454267a397c3f64" />
<link rel="preload" href="https://www.newswise.com/assets/fonts/OptimaLTStd.woff2" as="font" type="font/woff2" crossorigin>
<link rel="preload" href="https://www.newswise.com/assets/fonts/OptimaLTStd.woff" as="font" type="font/woff" crossorigin>


<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
	new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
	j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
	'../../www.googletagmanager.com/gtm5445.html?id='+i+dl;f.parentNode.insertBefore(j,f);
	})(window,document,'script','dataLayer','GTM-WH9TSCN');</script>




<script async src="../../www.googletagmanager.com/gtag/js8330?id=G-8NWKVEHW7E"></script>
<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-8NWKVEHW7E'); </script>


<meta name="keywords" content="Newswise, Ovarian Cancer;Ovarian Cancer Research Alliance;high-grade serous carcinoma;high-grade serous ovarian cancer ;Immunotherapy;checkpoint blockade;kinase inhibitor;antibody-drug conjugate,Cancer, Clinical Trials, OBGYN, Women's Health, Cancer Center Featured Story 2,  Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)" />
<meta name="description" content="A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment." />
<meta name="verify-v1" content="G6V3B5za6BYmoQM4QGo6vP95BavX+zDyot3ZErFSVpQ=" />
<meta name="viewport" content="width=device-width" />
<meta property="og:description" id="og_description" content="A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment." />
<meta name="google-site-verification" content="KBsTBTdgpLL7lngW3yrdeGPxeMGRmnXV4sMsegvlxNQ" />
<meta property="og:title" id="og_title" content="First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer" />
<meta property="og:type" id="og_type" content="website" />
<link rel="image_src" href="https://www.newswise.com/assets/new/img/newswise-logo-square.jpg" />
<meta property="og:image" id="og_image" content="https://www.newswise.com/assets/new/img/newswise-logo-square.jpg" />
<link rel="apple-touch-icon" sizes="57x57" href="https://www.newswise.com/apple-icon-57x57.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.newswise.com/apple-icon-60x60.png">
<link rel="apple-touch-icon" sizes="72x72" href="https://www.newswise.com/apple-icon-72x72.png">
<link rel="apple-touch-icon" sizes="76x76" href="https://www.newswise.com/apple-icon-76x76.png">
<link rel="apple-touch-icon" sizes="114x114" href="https://www.newswise.com/apple-icon-114x114.png">
<link rel="apple-touch-icon" sizes="120x120" href="https://www.newswise.com/apple-icon-120x120.png">
<link rel="apple-touch-icon" sizes="144x144" href="https://www.newswise.com/apple-icon-144x144.png">
<link rel="apple-touch-icon" sizes="152x152" href="https://www.newswise.com/apple-icon-152x152.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://www.newswise.com/apple-icon-180x180.png">
<link rel="icon" type="image/png" sizes="192x192" href="https://www.newswise.com/android-icon-192x192.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://www.newswise.com/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="96x96" href="https://www.newswise.com/favicon-96x96.png">
<link rel="icon" type="image/png" sizes="16x16" href="https://www.newswise.com/favicon-16x16.png">
<link rel="manifest" href="https://www.newswise.com/manifest.json">
<meta name="msapplication-TileColor" content="#ffffff">
<meta name="msapplication-TileImage" content="/ms-icon-144x144.png">
<meta name="theme-color" content="#ffffff">
<link rel="canonical" href="first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer.html" />
<meta property="og:url" id="og_url" content="https://www.newswise.com/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer" />

<link rel="alternate" type="application/rss+xml" title="Newswise Latest News" href="https://feeds.feedburner.com/NewswiseLatestNews" />
<link rel="alternate" type="application/rss+xml" title="Newswise Science News" href="https://feeds.feedburner.com/NewswiseScinews" />
<link rel="alternate" type="application/rss+xml" title="Newswise Medical News" href="https://feeds.feedburner.com/NewswiseMednews" />
<link rel="alternate" type="application/rss+xml" title="Newswise Life News" href="https://feeds.feedburner.com/NewswiseLifenews" />
<link rel="alternate" type="application/rss+xml" title="Newswise Business News" href="https://feeds.feedburner.com/NewswiseBiznews" />

<link rel="stylesheet" type="text/css" href="https://www.newswise.com/assets/new/css/material_icons.css">
<link rel="stylesheet" type="text/css" href="https://www.newswise.com/assets/new/css/style.css" />
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">

<link rel="stylesheet" type="text/css" href="../../fonts.googleapis.com/icone91f.css?family=Material+Icons" />
<link rel="stylesheet" type="text/css" href="https://www.newswise.com/assets/newTheme/css/style.css" />
<link rel="stylesheet" type="text/css" href="https://www.newswise.com/assets/newTheme/css/skin_v1.css" />

<script async src="../../www.googletagmanager.com/gtag/js13fa?id=AW-734562396"></script>
<script> 
		window.dataLayer = window.dataLayer || []; 
		function gtag(){dataLayer.push(arguments);} 
		gtag('js', new Date()); 
		gtag('config', 'AW-734562396'); 
	</script>








<link rel="stylesheet" type="text/css" href="https://www.newswise.com/assets/new/plugins/bootstrap-filter-lightbox-gallery/css/glightbox.css" />

<script src="https://www.newswise.com/assets/new/js/jquery-3.3.1.slim.min.js"></script>
<script type="text/javascript" src="https://www.newswise.com/assets/new/js/3.3.1-jquery.min.js"></script>
<script src="https://www.newswise.com/assets/newTheme/js/vendor/modernizr-2.8.3-respond-1.4.2.min.js"></script>
<script src="https://www.newswise.com/assets/newTheme/js/plugins.js"></script>
<script src="https://www.newswise.com/assets/newTheme/js/main.js"></script>
<script type="text/javascript" src="https://www.newswise.com/assets/new/js/1.12.1-jquery-ui.min.js"></script>



<script async src="../../www.googletagmanager.com/gtag/js7dd1?id=UA-2820194-1"></script>
<script>
		window.dataLayer = window.dataLayer || [];
		function gtag(){dataLayer.push(arguments);}
		gtag('js', new Date());
		gtag('config', 'UA-2820194-1');
		</script>

<script async src="../../www.googletagmanager.com/gtag/js13fa?id=AW-734562396"></script>
<script> 
			window.dataLayer = window.dataLayer || []; 
			function gtag(){dataLayer.push(arguments);} 
			gtag('js', new Date()); 
			gtag('config', 'AW-734562396'); 
		</script>
<script type="text/javascript">
            window.fbAsyncInit = function () {
                FB.init({
                    appId: '890013651056181',
                    xfbml: true,
                    version: 'v2.2'
                });
            };
            (function (d, s, id) {
                var js, fjs = d.getElementsByTagName(s)[0];
                if (d.getElementById(id)) {
                    return;
                }
                js = d.createElement(s);
                js.id = id;
                js.src = "http://connect.facebook.net/en_US/sdk.js";
                fjs.parentNode.insertBefore(js, fjs);
            }(document, 'script', 'facebook-jssdk'));
        </script>


<script type="text/javascript">
		_atrk_opts = { atrk_acct:"UeW4n1aMp410N8", domain:"newswise.com",dynamic: true};
		(function() { var as = document.createElement('script'); as.type = 'text/javascript'; as.async = true; as.src = "https://certify-js.alexametrics.com/atrk.js"; var s = document.getElementsByTagName('script')[0];s.parentNode.insertBefore(as, s); })();
		</script>

</head>
<body class="  fixedwidth articlesview articles-no-sidebar article-770750">


<noscript><iframe src="../../www.googletagmanager.com/nsce24.html?id=GTM-WH9TSCN" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="site-container">

<header>
<nav class="navbar navbar navbar-expand-xl navbar-light navbar-expand">
<div class="container">
<div class="w-100">
<div class=" d-flex flex-wrap align-items-center justify-content-center justify-content-between">
<a title="Newswise logo" href="https://www.newswise.com/" target="_self" class="navbar-brand">
<img src="https://www.newswise.com/assets/newTheme/img/logo-newSkin.png" title="Newswise logo">
</a>
<button type="button" class="btn btn-menu d-flex d-lg-none toggle-nav"><i class="material-icons">menu</i></button>
<ul class="nav offcanvas-collapse justify-content-end d-none d-lg-flex">

<li class="nav-item dropdown mega-menu-wrap">
<a role="button" aria-haspopup="true" aria-expanded="false" href="#" target="_self" data-bs-toggle="dropdown" class="nav-link dropdown-toggle dropdown-toggle-no-caret"><i class="material-icons">apps</i></a>
<ul tabindex="-1" class="dropdown-menu">
<div class="container">
<div class="row pt-4">
<div class="col col-6 dropdown-menu-parent">
<div class="dropdown-menu-wrap pl-0 pb-0">
<li role="presentation">
<header id="dropdown-header-label" class="dropdown-header" id="about_nw">About</header>
</li>
</div>
</div>
</div>
<div class="row">
<div class="col col-5 col-md-4 col-lg-3 dropdown-menu-parent">
<div class="dropdown-menu-wrap n-p pt-0">
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/memberservices" target="_self" class="dropdown-item" id="member_services_nw">Member Services</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/pricing" target="_self" class="dropdown-item" id="pricing_nw">Pricing</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/accessibility" target="_self" class="dropdown-item" id="accessibility_statement_nw">Accessibility Statement</a></li>
<li role="presentation"><a role="menuitem" href="https://memberservices.newswise.com/fast-pitch/" target="_self" class="dropdown-item" id="newswise_live_nw">Newswise Live</a></li>
<li role="presentation"><a role="menuitem" href="https://payments.newswise.com/invoicelookup" target="_self" class="dropdown-item" id="invoice_lookup_nw">Invoice Lookup</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/journalists" target="_self" class="dropdown-item" id="services_for_journalists_nw">Services for Journalists</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/archive/wires/" target="_self" class="dropdown-item" id="archived_wires_nw">Archived Wires</a></li>
</div>
</div>
<div class="col col-4 col-md-4 col-lg-3 dropdown-menu-parent">
<div class="dropdown-menu-wrap n-p pt-0">
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/media" target="_self" class="dropdown-item" id="media_subscribers_nw">Media Subscribers</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/reports/demo" target="_self" class="dropdown-item" id="sample_effectiveness_reports_nw">Sample Effectiveness Reports</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/terms-of-service" target="_self" class="dropdown-item" id="terms_of_service_nw">Terms of Service</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/privacy" target="_self" class="dropdown-item" id="privacy_policy_nw">Privacy Policy</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/newswise-staff" target="_self" class="dropdown-item" id="our_staff_nw">Our Staff</a></li>
</div>
</div>
<div class="col col-3 col-md-4 col-lg-6 dropdown-menu-parent text-right">
<div class="dropdown-menu-wrap n-p pt-0">
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/home/contact" target="_self" class="dropdown-item">Contact Us</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/ee/list/" target="_self" class="dropdown-item" id="blog_nw">Blog</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/home/faq/" target="_self" class="dropdown-item" id="faq_nw">FAQ</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/home/contact" target="_self" class="dropdown-item" id="help_nw">Help</a></li>
</div>
</div>
</div>
</div>
</ul>
</li>


<li class="nav-item dropdown mega-menu-wrap">
<a role="button" aria-haspopup="true" aria-expanded="false" href="#" target="_self" data-bs-toggle="dropdown" class="nav-link dropdown-toggle" id="news_nw">News</a>
<ul tabindex="-1" class="dropdown-menu">
<div class="container">
<div class="row">
<div class="col col-4 col-md-3 col-lg-3 has-spr dropdown-menu-parent">
<div class="dropdown-menu-wrap n-p">
<li role="presentation"><a role="menuitem" href="list/latest-news.html" target="_self" class="dropdown-item" id="latest_news_nw">Latest News</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/coronavirus" target="_self" class="dropdown-item" id="coronavirus_news_nw">Coronavirus News</a></li>
<li role="presentation"><a role="menuitem" href="list/embargoed-news.html" target="_self" class="dropdown-item" id="currently_embargoed_nw">Currently Embargoed</a></li>
<li role="presentation"><a role="menuitem" href="list/research-news.html" target="_self" class="dropdown-item" id="research_news_releases_nw">Research News Releases</a>
<li role="presentation"><a role="menuitem" href="list/fact-check-news.html" target="_self" class="dropdown-item" id="google_fact_check_nw">Google Fact Check</a></li>
<li role="presentation"><a role="menuitem" href="list/research-alert.html" target="_self" class="dropdown-item" id="research_alert_nw">Research Alert</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/preprints" target="_self" class="dropdown-item" id="preprints_nw">Preprints</a></li>
<li role="presentation"><a role="menuitem" href="list/marketplace-news.html" target="_self" class="dropdown-item" id="marketplace_nw">Marketplace</a></li>
<li role="presentation"><a role="menuitem" href="list/audiovideo.html" target="_self" class="dropdown-item" id="news_with_video_audio_nw">News With Video/Audio</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/multimedia" target="_self" class="dropdown-item" id="multimedia_nw">Multimedia</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/libraries/rss" target="_self" class="dropdown-item" id="rss_nw">RSS</a></li>
</div>
</div>
<div class="col col-4 col-md-3 col-lg-3 has-spr dropdown-menu-parent has-sub">
<div class="dropdown-menu-wrap n-p">
<header id="dropdown-header-label" class="dropdown-header" id="channels_nw"><a href="https://www.newswise.com/channels">Channels</a></header>
<li role="presentation" class="medicine-link">
<a onclick="activeMenu('medicine');" role="menuitem" href="#!" target="_self" class="dropdown-item hover" id="medicine_nw">Medicine
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="science-link">
<a onclick="activeMenu('science');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="science_nw">Science
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="life-link">
<a onclick="activeMenu('life');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="life_nw">Life
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="business-link">
<a onclick="activeMenu('business');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="business_nw">Business
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="journal-link">
<a onclick="activeMenu('journal');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="journal_news_nw">Journal News
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="location-link">
<a onclick="activeMenu('location');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="by_location_nw">By Location
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
<li role="presentation" class="events-link">
<a onclick="activeMenu('events');" role="menuitem" href="#!" target="_self" class="dropdown-item" id="meeting_grants_events_nw">Meeting, Grants &amp; Events
<svg viewBox="0 0 16 16" width="1em" height="1em" focusable="false" role="img" aria-label="chevron right" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="currentColor" class="bi-chevron-right float-right b-icon bi"><g><path fill-rule="evenodd" d="M4.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L10.293 8 4.646 2.354a.5.5 0 0 1 0-.708z"></path></g></svg>
</a>
</li>
</div>
</div>
<div class="col col-4 col-md-6 col-lg-4 sub-menu-wrap">
<div class="sub-menu medicine-menu">
<div class="row pt-4">
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/biotech.html?channel=6240" target="_self" class="dropdown-item" id="biotech_nw">Biotech</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/cancer/" target="_self" class="dropdown-item" id="cancer_nw">Cancer</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/coronavirus/" target="_self" class="dropdown-item" id="coronavirus-covid-19-nw">Coronavirus/COVID-19</a></li>
<li role="presentation"><a role="menuitem" href="channels/clinical-trials.html?channel=6502" target="_self" class="dropdown-item" id="clinical_trials_nw">Clinical Trials</a></li>
<li role="presentation"><a role="menuitem" href="channels/diabetes.html?channel=97" target="_self" class="dropdown-item" id="diabetes_nw">Diabetes</a></li>
<li role="presentation"><a role="menuitem" href="channels/genetics.html?channel=106" target="_self" class="dropdown-item" id="genetics_nw">Genetics</a></li>
<li role="presentation"><a role="menuitem" href="channels/infectious-diseases.html?channel=43" target="_self" class="dropdown-item" id="infectious_disease_nw">Infectious Disease</a></li>
<li role="presentation"><a role="menuitem" href="channels/neuro.html?channel=104" target="_self" class="dropdown-item" id="neuro_nw">Neuro</a></li>
</div>
</div>
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/obesity/" target="_self" class="dropdown-item" id="obesity_nw">Obesity</a></li>
<li role="presentation"><a role="menuitem" href="channels/women-s-health.html?channel=143" target="_self" class="dropdown-item" id="women_health_nw">Women's Health</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/medical-news/1" target="_self" class="view-all" id="view_all_medicine_channels_nw">View all Medicine Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu science-menu">
<div class="row pt-4">
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/chemistry.html?channel=144" target="_self" class="dropdown-item" id="chemistry_nw">Chemistry</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/climate/" target="_self" class="dropdown-item" id="climate_science_nw">Climate Science</a></li>
<li role="presentation"><a role="menuitem" href="channels/dinosaurs.html?channel=112" target="_self" class="dropdown-item" id="dinosaurs_nw">Dinosaurs</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/doescience/" target="_self" class="dropdown-item" id="doe_science_news_nw">DOE Science News</a></li>
<li role="presentation"><a role="menuitem" href="channels/engineering.html?channel=6269" target="_self" class="dropdown-item" id="engineering_nw">Engineering</a></li>
<li role="presentation"><a role="menuitem" href="channels/materials-science.html?channel=142" target="_self" class="dropdown-item" id="materials_science_nw">Materials Science</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/physics/" target="_self" class="dropdown-item" id="physics_nw">Physics</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/space/" target="_self" class="dropdown-item" id="space_nw">Space</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/science-news/2" target="_self" class="view-all" id="view_all_science_channels_nw">View all Science Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu life-menu">
<div class="row pt-4">
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/behavioral-science.html?channel=109" target="_self" class="dropdown-item" id="behavioral_science_nw">Behavioral Science</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/education/" target="_self" class="dropdown-item" id="education_nw">Education</a></li>
<li role="presentation"><a role="menuitem" href="channels/government-law.html?channel=16" target="_self" class="dropdown-item" id="government_nw">Government</a></li>
<li role="presentation"><a role="menuitem" href="channels/history.html?channel=6248" target="_self" class="dropdown-item" id="history_nw">History</a></li>
<li role="presentation"><a role="menuitem" href="https://www.newswise.com/politics/" target="_self" class="dropdown-item" id="politics_nw">Politics</a></li>
<li role="presentation"><a role="menuitem" href="channels/social-media.html?channel=6308" target="_self" class="dropdown-item" id="social_media_nw">Social Media</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/life-news/3" target="_self" class="view-all" id="view_all_life_channels_nw">View all Life Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu business-menu">
<div class="row pt-4">
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/economics.html?channel=79" target="_self" class="dropdown-item" id="economics_nw">Economics</a></li>
<li role="presentation"><a role="menuitem" href="channels/wall-street.html?channel=6252" target="_self" class="dropdown-item" id="wall_street_nw">Wall Street</a></li>
<li role="presentation"><a role="menuitem" href="channels/in-the-workplace.html?channel=136" target="_self" class="dropdown-item" id="in_the_workplace_nw">In the Workplace</a></li>
<li role="presentation"><a role="menuitem" href="channels/women-in-business.html?channel=6280" target="_self" class="dropdown-item" id="women_in_business_nw">Women in Business</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/business-news/4" target="_self" class="view-all" id="view_all_business_channels_nw">View all Business Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu journal-menu">
<div class="row pt-4">
<div class="col col-12">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/cell-journal.html?channel=6452" target="_self" class="dropdown-item" id="cell_journal_nw">Cell (journal)</a></li>
<li role="presentation"><a role="menuitem" href="channels/jama.html?channel=6335" target="_self" class="dropdown-item" id="jama_nw">JAMA</a></li>
<li role="presentation"><a role="menuitem" href="channels/journal-of-experimental-medicine.html?channel=6454" target="_self" class="dropdown-item" id="journal_of_experimental_medicine_nw">Journal of Experimental Medicine</a></li>
<li role="presentation"><a role="menuitem" href="channels/nature-journal.html?channel=6337" target="_self" class="dropdown-item" id="nature_journal_nw">Nature (journal)</a></li>
<li role="presentation"><a role="menuitem" href="channels/nejm.html?channel=6424" target="_self" class="dropdown-item" id="nejm_nw">NEJM</a></li>
<li role="presentation"><a role="menuitem" href="channels/neurology-journal.html?channel=6455" target="_self" class="dropdown-item" id="neurology_journal_nw">Neurology (journal)</a></li>
<li role="presentation"><a role="menuitem" href="channels/plos.html?channel=6334" target="_self" class="dropdown-item" id="plos_nw">PLoS</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/journal-news/5" target="_self" class="view-all" id="view_all_journal_channels_nw">View all Journal Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu location-menu">
<div class="row pt-4">
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/afghanistan-news.html?channel=6292" target="_self" class="dropdown-item" id="afghanistan_news_nw">Afghanistan News</a></li>
<li role="presentation"><a role="menuitem" href="channels/african-news.html?channel=6324" target="_self" class="dropdown-item" id="african_news_nw">African News</a></li>
<li role="presentation"><a role="menuitem" href="channels/china-news.html?channel=81" target="_self" class="dropdown-item" id="china_news_nw">China News</a></li>
<li role="presentation"><a role="menuitem" href="channels/cuba-news.html?channel=86" target="_self" class="dropdown-item" id="cuba_news_nw">Cuba News</a></li>
<li role="presentation"><a role="menuitem" href="channels/europe-news.html?channel=6322" target="_self" class="dropdown-item" id="europe_news_nw">Europe News</a></li>
<li role="presentation"><a role="menuitem" href="channels/germany-news.html?channel=6486" target="_self" class="dropdown-item" id="germany_news_nw">Germany News</a></li>
<li role="presentation"><a role="menuitem" href="channels/gulf-of-mexico.html?channel=6441" target="_self" class="dropdown-item" id="gulf_of_mexico_nw">Gulf of Mexico</a></li>
</div>
</div>
<div class="col col-12 col-md-6">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/india-news.html?channel=6496" target="_self" class="dropdown-item" id="india_pakistan_news_nw">India/Pakistan News</a></li>
<li role="presentation"><a role="menuitem" href="channels/iraq-news.html?channel=19" target="_self" class="dropdown-item" id="iraq_news_nw">Iraq News</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/by-location-news/7" target="_self" class="view-all" id="view_all_by_location_channels_nw">View all by Location Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
<div class="sub-menu events-menu">
<div class="row pt-4">
<div class="col col-12">
<div class="dropdown-menu-wrap">
<li role="presentation"><a role="menuitem" href="channels/grant-funded-news.html?channel=6296" target="_self" class="dropdown-item" id="grant_funded_news_nw">Grant Funded News</a></li>
<li role="presentation"><a role="menuitem" href="channels/medical-meetings.html?channel=6297" target="_self" class="dropdown-item" id="medical_meetings_nw">Medical Meetings</a></li>
<li role="presentation"><a role="menuitem" href="channels/newswise-live-event-in-progress.html?channel=6331" target="_self" class="dropdown-item" id="newswise_live_event_in_progress_nw">Newswise Live - Event in Progress</a></li>
<li role="presentation"><a role="menuitem" href="channels/newswise-live-expert-spotlight.html?channel=6407" target="_self" class="dropdown-item" id="newswise_live_expert_spotlight_nw">Newswise Live - Expert Spotlight</a></li>
<li role="presentation"><a role="menuitem" href="channels/newswise-live-events.html?channel=6323" target="_self" class="dropdown-item" id="newswise_live_events_nw">Newswise Live - Events</a></li>
<li role="presentation"><a role="menuitem" href="channels/scientific-meetings.html?channel=6298" target="_self" class="dropdown-item" id="scientific_meetings_nw">Scientific Meetings</a></li>
</div>
</div>
<div class="col-12">
<a title="" href="https://www.newswise.com/channels/meeting-grants-events/8" target="_self" class="view-all" id="view_all_meeting_grants_events_channels_nw">View all Meeting, Grants &amp; Events Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</div>
</div>
<div class="col col-12 col-lg-2 p-0 text-right">
<div class="dropdown-menu-wrap n-p mr-0 mr-md-2">
<div class="ad">
<p>sign up for the wires and see archived wires </p>
<li role="presentation" class="dropdown-btn"><a role="menuitem" href="#" target="_self" class="dropdown-item">sign up now</a></li>
</div>
</div>
</div>
</div>
</div>
</ul>
</li>

<li class="nav-item dropdown mega-menu-wrap">
<a role="button" aria-haspopup="true" aria-expanded="false" href="#" target="_self" data-bs-toggle="dropdown" class="nav-link dropdown-toggle" id="experts_nw">Experts</a>
<ul tabindex="-1" class="dropdown-menu">
<div class="container">
<div class="row">
<div class="col col-12 pt-3">
<div class="dropdown-menu-wrap n-p pt-4">
<div class="row">
<div class="col-4">
<div class="col-item has-border-r">
<li role="presentation">
<a role="menuitem" href="listadb2.html?category=expert-pitch" target="_self" class="dropdown-item" id="expert_pitch_nw">
<h6>Expert Pitch</h6>
<p>Browse experts available to comment on breaking news</p>
</a>
</li>
</div>
</div>
<div class="col-4">
<div class="col-item has-border-r">
<li role="presentation">
<a role="menuitem" href="https://www.newswise.com/resources/expert-query" target="_self" class="dropdown-item" id="expert_query_nw">
<h6>Expert Query</h6>
<p>Request an expert contact, get responses directly to your inbox</p>
</a>
</li>
</div>

</div>
<div class="col-4">
<div class="col-item">
<li role="presentation">
<a role="menuitem" href="https://www.newswise.com/users/expert-list/" target="_self" class="dropdown-item" id="expert_directory_nw">
<h6>Expert Directory</h6>
<p>Find an expert by topic in a comprehensive database</p>
</a>
</li>
</div>
</div>
</div>
</div>
</div>

</div>
</div>
</ul>
</li>


<li class="nav-item">
<a href="https://www.newswise.com/journalists" target="_self" class="nav-link">Journalists</a>
</li>

<li class="nav-item">
<a href="https://www.newswise.com/pricing" target="_self" class="nav-link" id="pricing_nw">Pricing</a>
</li>
</ul>
<ul class="nav offcanvas-collapse justify-content-end d-none d-lg-flex text-end">

<li class="nav-item dropdown mega-menu-wrap search-btn">
<form class="form-inline search" method="post" action="https://www.newswise.com/search/advanced">

<div role="group" class="input-group">
<input type="text" placeholder="Search ..." name="search[text]" id="q" class="form-control search-field" accesskey="s" tabindex="0">
<div class="input-group-append">
<button type="submit" id="searchbutton" class="btn btn-main btn-btn"><i class="material-icons">search</i></button>
</div>
</div>
</form>
</li>
<li class="nav-item dropdown mega-menu-wrap search-btn">
<ul tabindex="-1" class="dropdown-menu">
<div class="container">
<div class="row">
<div class="col col-12 pl-0 has-spr dropdown-menu-parent">



</div>
</div>
</div>
</ul>
</li>

<a href="https://memberservices.newswise.com/request-a-demo-campaign" target="_self" class="btn btn-main">Request a Demo</a>
<li class="nav-item b-nav-dropdown dropdown mega-menu-wrap">
<a role="button" aria-haspopup="true" aria-expanded="false" href="https://www.newswise.com/users/login/?ret=%2Farticles%2Ffirst-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer" target="_self" class="nav-link">Login</a>
</li>
<li class="nav-item b-nav-dropdown dropdown mega-menu-wrap">
<a role="button" aria-haspopup="true" aria-expanded="false" href="https://www.newswise.com/users/register?ret=%2Farticles%2Ffirst-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer" target="_self" class="nav-link">Register</a>
</li>
</ul>
</div>
</div>
</div>
</nav>
</header>
<div class="banner">
<div class="container"></div>
</div>


<div class="container">
<div id="flash" class="new-alert padzero"></div>
</div>
<style>
.article-view .rtl_article .article-context p, .article-view .rtl_article .article-context a, .article-view .rtl_article .article-context li{
    direction: rtl;
}
.article-view .article-title.rtl_article h1 {
    direction: rtl;
    text-align: right;
    padding: 0;
}
.article-view.reporter-query .article-title .editor-menu {
    position: absolute;
    right: 0;
    top: -30px;
}
</style>
<script type="application/ld+json">
    {
        "@context": "https://schema.org",
        "@type":  "NewsArticle" ,
        "mainEntityOfPage": {
            "@type": "WebPage",
            "@id": "https://www.newswise.com/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer"
        },
        "url": "https://www.newswise.com/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer",
        "headline": "First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer",
        "thumbnailUrl": "https://www.newswise.com/legacy/image.php?image=",
        "image": {
            "@type": "ImageObject",
            "url": "https://www.newswise.com/legacy/image.php?image=",
            "width": 1200,
            "height": 600
        },
        "datePublished": "2022-05-11",
        "dateModified": "2022-05-11",
        "author": {
            "@type": "Organization",
            "name": "Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)",
            "identifier": "10001369",
            "url": "https://www.newswise.com/institutions/newsroom/10001369",
            "description": "",
            "image": {
                "@type": "ImageObject",
                "url": "https://www.newswise.com/legacy/image.php?image=/images/institutions/logos/CRI OCRA logo20220511082083.jpg"
            }
        },
        "publisher": {
        "@type": "Organization",
        "name": "Newswise",
        "logo": {
            "@type": "ImageObject",
            "url": "https://www.newswise.com/assets/new/img/Newswise-Logo.png"
            }
        },
        "description": "A phase 2 clinical trial testing novel immunotherapy combinations in aggressive ovarian cancer has opened and first patients have begun treatment.",
        "keywords": ["Ovarian Cancer;Ovarian Cancer Research Alliance;high-grade serous carcinoma;high-grade serous ovarian cancer ;Immunotherapy;checkpoint blockade;kinase inhibitor;antibody-drug conjugate"]}
</script>
<script>
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-2820194-1']);
// set custom variables
_gaq.push(["_setCustomVar", 1, "Cancer Research Institute", "1912", 1]);
_gaq.push(["_setCustomVar", 2, "Release Date", "5/11/2022", 1]);
// track page view
_gaq.push(['_trackPageview']);

(function() {
	var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
	ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
	var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
})();
</script>
<div class="container">
<div class="row">
<div class="article-view ">
<div class="box-container">
<div class="article-title ">

<div class="row align-items-center">
<div class="col-md-9 col-sm-9 col-xs-12 ">
<h1>First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer</h1>
<h6 class="news_form"><i>•	Patients with ovarian cancer of the high-grade serous carcinoma subtype and that no longer respond to treatment with platinum-based therapy will receive a PD-L1-blocking antibody along with one of two antibody-drug conjugates targeting overexpressed receptor tyrosine kinases in the first two cohorts of this study
•	Multiple sites across Canada and the U.S. open in 2022
•	Combination immunotherapy may offer hope to the 80 percent of patients with this type of ovarian cancer who relapse</i></h6>
</div>
<div class="col-md-2 col-sm-3 col-xs-12">
 <img class="img-fluid" src="https://www.newswise.com/images/institutions/logos/CRI OCRA logo20220511082083.jpg" alt="Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)" width="360px">
</div>
</div>
</div>
<div class="article-pub-info_share">
<div class="row">
<div class="col-12 col-md-8">
<div class="pub-info">
<span class="pub-date">11-May-2022 8:00 AM EDT</span>,
<span class="pub-author"><span class="text-muted">by</span> <a href="https://www.newswise.com/institutions/newsroom/10001369/">Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA)</a></span>
</div>
</div>
<div class="col-12 col-md-4 text-md-right">

<div class="addthis_inline_share_toolbox" style="display: inline-block;float: right;"></div>
<a class="ad_favorites" href="https://www.newswise.com/users/login/?ret=%2Farticles%2Ffirst-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer%2F%3Fad2f%3D1%26aid%3D770750" title="Add to Favorites" style="background: #dc3545; display: inline-block; padding: 2px 4px; color: #fff; float: right;"><i class="material-icons">favorite_border</i></a>
</div>
</div>
</div>
<div class="article-body ">
<div class="row">
<div class="col col-md-9">
<div class="article-main ">
<div class="media-view">
<div class="embed-responsive embed-responsive-16by9">

<script type="text/javascript">	
												var images_count = 0;
												var item_id = 770750;
												var media_count = 0;
												var audio_count = 0;
												var video_count = 0;
																								var channel = '';
												var section = '';
																							</script>
<div class="custom-view-artical-changes">
</div>
</div>
</div>
<div class="article-context">
<p><p>Newswise &#8212; NEW YORK, May 11, 2022 &mdash; The Cancer Research Institute (CRI) and Ovarian Cancer Research Alliance (OCRA) announced today that the first patients have been dosed in their new multi-center platform clinical trial testing novel cancer immunotherapy combinations in patients with a common and highly aggressive form of ovarian cancer that has become resistant to treatment with platinum-based chemotherapy.</p><p>Currently, the majority of ovarian cancers &ndash; upwards of 75 percent &ndash; are of the subtype &ldquo;high-grade serous carcinoma,&rdquo; which is the type being treated in this phase 2 study. While most patients with this malignant ovarian cancer subtype initially respond to standard cytotoxic therapies, more than 80 percent will relapse and succumb to the disease within five years. New treatments are urgently needed for this deadliest of gynecological cancers, which is diagnosed in more than a quarter-million women worldwide each year according to World Health Organization estimates.</p><p>This phase 2 trial titled, &ldquo;<u>I</u>mmunotherapy Platform Study in <u>P</u>latinum <u>R</u>esistant High Grade Serous <u>O</u>varian <u>C</u>ancer (IPROC)&rdquo; (<a href="https://www.clinicaltrials.gov/ct2/show/NCT04918186">NCT04918186</a>), is co-funded by CRI and OCRA and is sponsored by CRI clinical partner the Canadian Cancer Trials Group (CCTG), and is open and actively recruiting patients to sites in Canada and, in the second half of 2022, will open sites in the United States. Overall, up to 60 patients are planned to be enrolled in this platform study with up to 40 patients in these two initial cohorts.</p><p>This clinical trial is using an adaptive platform study design that utilizes a single master protocol that allows for multiple treatments to be evaluated in different groups of patients, or cohorts, from the same patient population. Such a study design offers flexibility in that different treatments can be evaluated in different cohorts, treatment regimens can be modified between cohorts, and treatment selection criteria can be customized for a specific cohort.</p><p>Immunotherapy as monotherapy in treating patients with this aggressive type of ovarian cancer has not resulted in improvement in patient outcomes. In contrast, a recent randomized Phase 2 trial led by Dmitriy Zamarin, M.D., Ph.D., a member of the Cancer Research Institute Drug Selection Committee and study chair on the IPROC platform trial, demonstrated a three-fold improvement in overall response rates among ovarian cancer patients treated with a combination of immunotherapies compared to patients treated with a single immunotherapy.</p><p>&ldquo;The IPROC trial builds upon the results seen in positive immunotherapy combination studies in ovarian cancer, and was designed in collaboration with our partners to explore each patient&rsquo;s immunological response to determine which combinations result in the greatest patient benefit and why they are more effective than other combinations,&rdquo; said Jay Campbell, managing director of the Anna-Maria Kellen Clinical Accelerator and Venture Fund at the Cancer Research Institute.</p><p>Patients with high grade serous ovarian cancer that is refractory or resistant to platinum-based cytotoxic therapy will be assigned to one of two cohorts testing novel immunotherapy combinations with drugs supplied by AstraZeneca and BioAtla, Inc.: Cohort A will receive AstraZeneca&rsquo;s PD-L1-blocking antibody durvalumab (IMFINZI&reg;) in combination with BioAtla&rsquo;s BA3011 (mecbotamab vedotin), a conditionally active antibody-drug conjugate targeting AXL, a receptor tyrosine kinase that is overexpressed across many solid tumor types, while Cohort B will receive durvalumab in combination with BioAtla&rsquo;s BA3021 (ozuriftamab vedotin), a conditionally active antibody-drug conjugate targeting ROR2, another receptor tyrosine kinase that is overexpressed in solid tumors. As part of the eligibility evaluation process, patients will be screened for expression levels of AXL or ROR2 and eligible patients will be assigned to the appropriate cohort accordingly.</p><p>&ldquo;Ovarian cancer patients are in dire need of additional treatment options, and partnering with the Cancer Research Institute on this innovative platform trial is a crucial step in our efforts to hasten drug development,&rdquo; said Audra Moran, president and CEO of Ovarian Cancer Research Alliance. &ldquo;This collaboration allows OCRA to have a direct impact on future outcomes for our patients as well as add to the collective understanding of this disease.&rdquo;</p><p>&ldquo;We are excited to move forward in partnership with CRI, OCRA, and our collaborators with this important study. IPROC&rsquo;s innovative trial design means that we can accelerate the pace of discovery in understanding how to optimize immunotherapy for the treatment of patients diagnosed with ovarian cancer,&rdquo; said CCTG study lead Helen MacKay, MBChB, B.Sc., MRCP, M.D.</p><p>&ldquo;Our hope is that the immunotherapy combinations we are studying in this clinical trial will do better than current standard-of-care treatments, providing ovarian cancer patients with much-needed therapeutic options and better odds of survival,&rdquo; said Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, director of the University of Chicago Comprehensive Cancer Center and a study co-chair.</p><p><strong>Key industry and academic partners</strong></p><p>This clinical trial is the third to result from the collaboration formed in 2018 between CRI and CCTG, a Canada-based cooperative oncology group that is sponsoring the study. AstraZeneca is collaborating to support this study. BioAtla, Inc., is supplying BA3011 and BA3021 as well as co-funding to support this study.</p><p><strong><u>About the Trial</u></strong></p><p><strong>Title:</strong> <u>I</u>mmunotherapy Platform Study in <u>P</u>latinum <u>R</u>esistant High Grade Serous <u>O</u>varian <u>C</u>ancer (IPROC) (<a href="https://www.clinicaltrials.gov/ct2/show/NCT04918186">NCT04918186</a>)</p><p><strong>Study Chairs: </strong></p><ul><li>Helen MacKay, MBChB, B.Sc., MRCP, M.D., Head, Division of Medical Oncology and Hematology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON Canada</li><li>Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, Director, University of Chicago Comprehensive Cancer Center, Chicago, IL USA</li><li>Anna Tinker, M.D., FRCPC, Medical Oncologist, British Columbia Cancer, Vancouver Centre, BC Canada</li><li>Dmitriy Zamarin, M.D., Ph.D., Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York, NY USA</li></ul><p></p><p><strong>About IMFINZI&reg; (durvalumab)<br /></strong>AstraZeneca&rsquo;s IMFINZI is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with PD-1 and CD80, countering the tumor&rsquo;s immune-evading tactics and releasing the inhibition of immune responses.</p><p><strong>About Mecbotamab Vedotin (BA3011)<br /></strong>BioAtla&rsquo;s BA3011, CAB-AXL-ADC, is a conditionally and reversibly active antibody-drug conjugate targeting the receptor tyrosine kinase AXL that is overexpressed across multiple different solid tumors.</p><p><strong>About Ozuriftamab Vedotin (BA3021)<br /></strong>BioAtla&rsquo;s BA3021, CAB-ROR2-ADC, is a conditionally and reversibly active antibody-drug conjugate directed against ROR2, a receptor tyrosine kinase that is overexpressed across many different solid tumors.</p><p><strong>About the Cancer Research Institute<br /></strong>The Cancer Research Institute (CRI), established in 1953, is a highly rated U.S. nonprofit organization dedicated exclusively to saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. Guided by a world-renowned Scientific Advisory Council that includes four Nobel laureates and 27 members of the National Academy of Sciences, CRI has invested $474 million in support of research conducted by immunologists and tumor immunologists at the world&rsquo;s leading medical centers and universities and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of cancer treatment. To learn more, go to <a href="https://www.cancerresearch.org/">cancerresearch.org</a> and follow CRI on Twitter @CancerResearch.</p><p><strong>About the CRI Anna-Maria Kellen Clinical Accelerator<br /></strong>CRI&rsquo;s clinical program, the Anna-Maria Kellen Clinical Accelerator is a unique academic-nonprofit-industry collaboration model that serves an as &ldquo;incubator&rdquo; that delivers multicenter clinical trials of promising new immunotherapy combinations. CRI&rsquo;s venture philanthropy fund supports clinical trials within the program, which fosters a collaborative environment that enables scientists to advance their most ambitious research ideas by accelerating studies that one group or company could not do alone. To learn more, go to <a href="https://www.cancerresearch.org/en-us/scientists/clinical-accelerator">cancerresearch.org/clinical-accelerator</a>.</p><p><strong>About Ovarian Cancer Research Alliance<br /></strong>Ovarian Cancer Research Alliance (OCRA) is the largest non-government funder of ovarian cancer research and has invested $110 million in research since its founding. OCRA fights ovarian cancer from all fronts, including in the lab and on Capitol Hill, and through innovative programs to support patients and their families.</p><p>OCRA&rsquo;s ongoing investments in the most promising scientific research is funding discoveries, creating new treatments, and hastening desperately needed breakthroughs. OCRA is <em>the</em> voice for the ovarian cancer community, working with legislators to ensure federal ovarian cancer research and education, patient safety, and access to high-quality care are protected on Capitol Hill.&nbsp;OCRA&rsquo;s programs help people navigate their diagnosis and support patients and their families when and where they need it most. Visit <a href="https://www.ocrahope.org/">ocrahope.org</a> to learn more</p><p><strong>About Canadian Cancer Trials Group <br /></strong>The <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3380824-1&amp;h=3165841910&amp;u=http%3A%2F%2Fwww.cctg.ca%2F&amp;a=Canadian+Cancer+Trials+Group">Canadian Cancer Trials Group</a> (CCTG) is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies at over 85 hospitals and cancer centers across Canada. From the operations center at <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3380824-1&amp;h=2798145111&amp;u=https%3A%2F%2Fprnnj3-irisxe10.prnewswire.local%2FUsers%2Fasahgal%2FAppData%2FLocal%2FMicrosoft%2FWindows%2FINetCache%2FContent.Outlook%2FXQE6JZUF%2Fqueensu.ca%2F&amp;a=Queen%27s+University">Queen's University</a>, CCTG has supported more than 600 trials enrolling 100,000 patients from 40 countries on 6 continents through a global network of 20,000 investigators and clinical trial staff. CCTG is a national program of the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3380824-1&amp;h=2778570141&amp;u=https%3A%2F%2Fwww.cancer.ca%2F&amp;a=Canadian+Cancer+Society">Canadian Cancer Society</a> and their aim is to improve survival and quality of life for all people with cancer.</p><p><strong>#&nbsp; #&nbsp; #</strong></p></p> </div>
<p class="journal_text text-center"></p>
</div>
</div>
<div class="col col-md-3 ">
<div class="article-side">
<div class="col-12 my-0 p-0 text-center">

<button class="btn btn-danger my-2 btn-block text-uppercase" onclick="window.location.href='https://www.newswise.com/resources/expert-query'">Request an Expert</button>
</div>
<div class="article-media-contact">
<h5>MEDIA CONTACT</h5>
<a href='https://www.newswise.com/users/register' class='btn btn-danger text-uppercase' target='_blank'>Register for reporter access to contact details</a> </div>



<div class="article-tags">
<h5>TYPE OF ARTICLE</h5>
<a href="list41f5.html?category=latest&amp;search[article_type]=1100" title="Clinical Trials" target="_blank">Clinical Trials</a>
</div>
 <div class="article-tags">
<h5>SECTION</h5>
<a href="list48ca.html?category=medicine" title="Show all articles in this channel" target="_blank"><label class="medicine-lb">MEDICINE</label></a> </div>
<div class="article-tags">
<h6>CHANNELS</h6>
<a href="https://www.newswise.com/cancer/" title="Show all articles in this channel" target='_blank'>Cancer</a> <a href="channels/clinical-trials.html?channel=6502" title="Show all articles in this channel" target='_blank'>Clinical Trials</a> <a href="channels/obgyn.html?channel=123" title="Show all articles in this channel" target='_blank'>OBGYN</a> <a href="channels/women-s-health.html?channel=143" title="Show all articles in this channel" target='_blank'>Women's Health</a> <a href="channels/cancer-center-featured-story-2.html?channel=6299" class="hidden" title="Show all articles in this channel (Staff note: hidden channel)" target='_blank'>Cancer Center Featured Story 2</a> </div>
<div class="article-tags">
<h6>KEYWORDS</h6>
<a href="https://www.newswise.com/search/advanced/?search[tag]=Ovarian%20Cancer" title="Search for articles tagged with this keyword or phrase" target='_blank'>Ovarian Cancer</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=Ovarian%20Cancer%20Research%20Alliance" title="Search for articles tagged with this keyword or phrase" target='_blank'>Ovarian Cancer Research Alliance</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=high-grade%20serous%20carcinoma" title="Search for articles tagged with this keyword or phrase" target='_blank'>high-grade serous carcinoma</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=high-grade%20serous%20ovarian%20cancer" title="Search for articles tagged with this keyword or phrase" target='_blank'>high-grade serous ovarian cancer </a> <a href="https://www.newswise.com/search/advanced/?search[tag]=Immunotherapy" title="Search for articles tagged with this keyword or phrase" target='_blank'>Immunotherapy</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=checkpoint%20blockade" title="Search for articles tagged with this keyword or phrase" target='_blank'>checkpoint blockade</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=kinase%20inhibitor" title="Search for articles tagged with this keyword or phrase" target='_blank'>kinase inhibitor</a> <a href="https://www.newswise.com/search/advanced/?search[tag]=antibody-drug%20conjugate" title="Search for articles tagged with this keyword or phrase" target='_blank'>antibody-drug conjugate</a> </div>
</div>
</div>

<div class="new_more_social text-center col-md-12">
 <div class="addthis_inline_share_toolbox_moc6"></div>
<div class="text-center commentdiv"><a href="https://www.newswise.com/home/contact/?topic=Article%20Comment&amp;subject=Comment%20for%20Article%20%23770750&amp;article=770750" title="Leave a comment..." target="_blank">COMMENTS</a> | <a href="https://www.newswise.com/ee/commentpolicy/" title="Newswise commenting policy" target="_blank">COMMENTING POLICY</a></div>
</div>

<style>
								.recommended-section {
									text-align: left;
								}
								.recommended-section img {
									width: 100%;
									height: 150px;
									object-fit: cover;
								}
								.recommended-section img.logo {
									object-fit: contain;
								}
								.recommended-section h2 {
									font-size: 1.25rem;
								}
								#recommended-section-content .row {
									box-shadow: 0px 0px 3px 0 #e6e6e6;
									padding: 15px 0;
									margin: 15px 0 0 0;
								}
							</style>
<div class="col-md-12 recommended-section">
<div class="view-all-cta mb-4">
<a href="list6592.html?category=latest" target="_blank" class="btn btn-block btn-danger">View All Latest News</a>
</div>
<h3 class="mb-3">Recommended For You</h3>
<div id="recommended-section-content" style="height:765px"></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>


<script>
	jQuery(document).ready(function () {
		jQuery.ajax({
			url: '/home/get-recommended-articles/',
			type: "POST",
			data: {
				article_id: "770750",
				rchannel: "9,6502,123,143,6299"
			},
			success: function (data) {
				//alert(data);
				jQuery('#recommended-section-content').html(data);
				}
		});	
		
	});
</script>
<script>
		jQuery(document).ready(function () {
			const queryString = window.location.search;
			jQuery.ajax({
				url: '/articles/log-article/'+queryString,
				type: "POST",
				data: {
					article_id: "770750",
					url: "/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer"
				},
				success: function (data) {
					console.log(data);
				}
			});	
		});
	</script>


<footer>
<div class="call2Act">
<div class="container">
<div class="row">
<div class="col-md-3">
<h2><span>Join</span> Newswise!</h2>
</div>
<div class="col-md-9">
<div class="about">
<p>Newswise gives journalists access to the latest news and provides a platform for
universities, institutions, and journalists to spread breaking news to their
audience.
</p>
<a class="btn btn-main" href="https://www.newswise.com/users/register">Subscribe to Newswise</a>
<a class="btn btn-secondary" href="https://www.newswise.com/journalists">For Journalists</a>
<a class="btn btn-tertiary" href="https://memberservices.newswise.com/request-a-demo-campaign/">Receive a Demo</a>
</div>
</div>
</div>
</div>
</div>
<div class="copyRight">
<div class="container">
<div class="row">
<div class="col-md-3"><img title="Newswise logo" src="https://www.newswise.com/assets/newTheme/img/logo-newSkin.png" alt="Newswise Logo"></div>

<div class="col-md-5">
<h4 class="mt-3"><a href="tel:+1434-296-9417"><i class="bi bi-telephone"></i> <span>434-296-9417</span></a></h4>
<p><a href="https://www.newswise.com/cdn-cgi/l/email-protection#177e7971785779726064607e64723974787a"><i class="bi bi-envelope"></i> <span><span class="__cf_email__" data-cfemail="3e575058517e505b494d49574d5b105d5153">[email&#160;protected]</span></span></a></p>
</div>
<div class="col-md-4">
<p>Newswise, Inc</p>
<ul class="list-inline">
<li class="list-inline-item"><a href="https://www.newswise.com/privacy" title="privacy">Privacy Notice</a></li>
<li class="list-inline-item"><a href="https://www.newswise.com/terms-of-service" title="terms-of-service">Terms of Service</a></li>
<li class="list-inline-item"><a href="https://www.newswise.com/home/contact" title="contact-us">Contact Us</a></li>
</ul>
</div>
</div>
</div>
</div>
</footer>

<div id="mobile-menu">
<a href="#!" title="" class="close-menu toggle-nav"><i class="material-icons">close</i></a>
<div class="search-area">
<form method="post" action="https://www.newswise.com/search/advanced">
<div class="input-group mb-3">
<input type="text" class="form-control" placeholder="Search ..." name="search[text]" id="q" accesskey="s" tabindex="0">
<div class="input-group-append">
<button class="btn btn-main" type="button"><i class="material-icons">search</i></button>
</div>
</div>
</form>
</div>
<ul class="navbar-nav">

<li class="nav-item"><a class="nav-link btn-main" href="https://www.newswise.com/users/login/?ret=%2Farticles%2Ffirst-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer">Login</a></li>
<ul class="navbar-nav menu staff" id="menu">
<li class="nav-item menu-item top">
<a class="nav-link collapsed" href="https://www.newswise.com/libraries" data-toggle="collapse" data-target="#sections-dd-menu" aria-expanded="false" id="news_nw">News <i class="material-icons">keyboard_arrow_right</i></a>
<div id="sections-dd-menu" class="collapse sub-menu">
<a class="dropdown-item" id="latest_news_nw" href="list/latest-news.html">Latest News</a>
<a class="dropdown-item" id="coronavirus_news_nw" href="https://www.newswise.com/coronavirus">Coronavirus News</a>
<a class="dropdown-item" id="currently_embargoed_news_nw" href="list/embargoed-news.html">Currently Embargoed News</a>

<a class="dropdown-item" id="research_news_releases_nw" href="list/research-news.html">Research News Releases</a>
<a class="dropdown-item" id="google_fact_check_nw" href="list/fact-check-news.html">Google Fact Check</a>
<a class="dropdown-item" id="research_alert_nw" href="list/research-alert.html">Research Alert</a>
<a class="dropdown-item" id="expert_query_nw" href="list/expert-query.html">Expert Query</a>
<a class="dropdown-item" id="preprints_nw" href="http://preprints/">Preprints</a>
<a class="dropdown-item" id="marketplace_nw" href="list/marketplace-news.html">Marketplace</a>
<a class="dropdown-item" id="news_with_video_audio_nw" href="list/audiovideo.html">News with Video/Audio</a>
<a class="dropdown-item" id="multimedia_nw" href="https://www.newswise.com/multimedia">Multimedia</a>
<a class="dropdown-item" id="rss_nw" href="https://www.newswise.com/libraries/rss"><img class="rss_logo" src="https://www.newswise.com/assets/new/img/rss-icon-logo.png" alt="RSS Icon">RSS</a>
<a class="dropdown-item collapsed" id="medicine_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-medicine-m" href="#!">Medicine <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-medicine-m" class="collapse">
<a role="menuitem" href="channels/biotech.html?channel=6240" target="_self" class="dropdown-item" id="biotech_nw">Biotech</a>
<a role="menuitem" href="https://www.newswise.com/cancer/" target="_self" class="dropdown-item" id="cancer_nw">Cancer</a>
<a role="menuitem" href="https://www.newswise.com/coronavirus/" target="_self" class="dropdown-item" id="coronavirus_covid_19_nw">Coronavirus/COVID-19</a>
<a role="menuitem" href="channels/clinical-trials.html?channel=6502" target="_self" class="dropdown-item" id="clinical_trials_nw">Clinical Trials</a>
<a role="menuitem" href="channels/diabetes.html?channel=97" target="_self" class="dropdown-item" id="diabetes_nw">Diabetes</a>
<a role="menuitem" href="channels/genetics.html?channel=106" target="_self" class="dropdown-item" id="genetics_nw">Genetics</a>
<a role="menuitem" href="channels/infectious-diseases.html?channel=43" target="_self" class="dropdown-item" id="infectious_disease_nw">Infectious Disease</a>
<a role="menuitem" href="channels/neuro.html?channel=104" target="_self" class="dropdown-item" id="neuro_nw">Neuro</a>
<a role="menuitem" href="https://www.newswise.com/obesity/" target="_self" class="dropdown-item" id="obesity_nw">Obesity</a>
<a role="menuitem" href="channels/women-s-health.html?channel=143" target="_self" class="dropdown-item" id="women_health_nw">Women?s Health</a>
<a title="" href="https://www.newswise.com/channels/medical-news/1" target="_self" class="view-all" id="view_all_medicine_channels_nw">View all Medicine Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
<a class="dropdown-item collapsed" id="science_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-science-m" href="#!">Science<i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-science-m" class="collapse">
<a role="menuitem" href="channels/chemistry.html?channel=144" target="_self" class="dropdown-item" id="chemistry_nw">Chemistry</a>
<a role="menuitem" href="https://www.newswise.com/climate/" target="_self" class="dropdown-item" id="climate_science_nw">Climate Science</a>
<a role="menuitem" href="channels/dinosaurs.html?channel=112" target="_self" class="dropdown-item" id="dinosaurs_nw">Dinosaurs</a>
<a role="menuitem" href="https://www.newswise.com/doescience/" target="_self" class="dropdown-item" id="doe_science_news_nw">DOE Science News</a>
<a role="menuitem" href="channels/engineering.html?channel=6269" target="_self" class="dropdown-item" id="engineering_nw">Engineering</a>
<a role="menuitem" href="channels/materials-science.html?channel=142" target="_self" class="dropdown-item" id="materials_science_nw">Materials Science</a>
<a role="menuitem" href="https://www.newswise.com/physics/" target="_self" class="dropdown-item" id="physics_nw">Physics</a>
<a role="menuitem" href="https://www.newswise.com/space/" target="_self" class="dropdown-item" id="space_nw">Space</a>
<a title="" href="https://www.newswise.com/channels/science-news/2" target="_self" class="view-all" id="view_all_science_channels_nw">View all Science Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
<a class="dropdown-item collapsed" id="life_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-life-m" href="#!">Life <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-life-m" class="collapse">
<a role="menuitem" href="channels/behavioral-science.html?channel=109" target="_self" class="dropdown-item" id="behavioral_science_nw">Behavioral Science</a>
<a role="menuitem" href="https://www.newswise.com/education/" target="_self" class="dropdown-item" id="education_nw">Education</a>
<a role="menuitem" href="channels/government-law.html?channel=16" target="_self" class="dropdown-item" id="government_nw">Government</a>
<a role="menuitem" href="channels/history.html?channel=6248" target="_self" class="dropdown-item" id="history_nw">History</a>
<a role="menuitem" href="https://www.newswise.com/politics/" target="_self" class="dropdown-item" id="politics_nw">Politics</a>
<a role="menuitem" href="channels/social-media.html?channel=6308" target="_self" class="dropdown-item" id="social_media_nw">Social Media</a>
<a title="" href="https://www.newswise.com/channels/life-news/3" target="_self" class="view-all" id="view_all_life_channels_nw">View all Life Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
<a class="dropdown-item collapsed" id="business_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-business-m" href="#!">Business <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-business-m" class="collapse">
<a role="menuitem" href="channels/economics.html?channel=79" target="_self" class="dropdown-item" id="economics_nw">Economics</a>
<a role="menuitem" href="channels/wall-street.html?channel=6252" target="_self" class="dropdown-item" id="wall_street_nw">Wall Street</a>
<a role="menuitem" href="channels/in-the-workplace.html?channel=136" target="_self" class="dropdown-item" id="in_the_workplace_nw">In the Workplace</a>
<a role="menuitem" href="channels/women-in-business.html?channel=6280" target="_self" class="dropdown-item" id="women_in_business_nw">Women in Business</a>
<a title="" href="https://www.newswise.com/channels/business-news/4" target="_self" class="view-all" id="view_all_business_channels_nw">View all Business Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
<a class="dropdown-item collapsed" id="journal_news_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-journal-news-m" href="#!">Journal News <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-journal-news-m" class="collapse">
<a role="menuitem" href="channels/cell-journal.html?channel=6452" target="_self" class="dropdown-item" id="cell_journal_nw">Cell (journal)</a>
<a role="menuitem" href="channels/jama.html?channel=6335" target="_self" class="dropdown-item" id="jama_nw">JAMA</a>
<a role="menuitem" href="channels/journal-of-experimental-medicine.html?channel=6454" target="_self" class="dropdown-item" id="journal_of_experimental_medicine_nw">Journal of Experimental Medicine</a>
<a role="menuitem" href="channels/nature-journal.html?channel=6337" target="_self" class="dropdown-item" id="nature_journal_nw">Nature (journal)</a>
<a role="menuitem" href="channels/nejm.html?channel=6424" target="_self" class="dropdown-item" id="nejm_nw">NEJM</a>
<a role="menuitem" href="channels/neurology-journal.html?channel=6455" target="_self" class="dropdown-item" id="neurology_journal_nw">Neurology (journal)</a>
<a role="menuitem" href="channels/plos.html?channel=6334" target="_self" class="dropdown-item" id="plos_nw">PLoS</a>
<a title="" href="https://www.newswise.com/channels/journal-news/5" target="_self" class="view-all" id="view_all_journal_channels_nw">View all Journal Channels <i class="material-icons">arrow_right_alt</i></a>
</div>

<a class="dropdown-item collapsed" id="by_location_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-location-m" href="#!">By Location <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-location-m" class="collapse">
<a role="menuitem" href="channels/afghanistan-news.html?channel=6292" target="_self" class="dropdown-item" id="afghanistan_news_nw">Afghanistan News</a>
<a role="menuitem" href="channels/african-news.html?channel=6324" target="_self" class="dropdown-item" id="african_news_nw">African News</a>
<a role="menuitem" href="channels/china-news.html?channel=81" target="_self" class="dropdown-item" id="china_news_nw">China News</a>
<a role="menuitem" href="channels/cuba-news.html?channel=86" target="_self" class="dropdown-item" id="cuba_news_nw">Cuba News</a>
<a role="menuitem" href="channels/europe-news.html?channel=6322" target="_self" class="dropdown-item" id="europe_news_nw">Europe News</a>
<a role="menuitem" href="channels/germany-news.html?channel=6486" target="_self" class="dropdown-item" id="germany_news_nw">Germany News</a>
<a role="menuitem" href="channels/gulf-of-mexico.html?channel=6441" target="_self" class="dropdown-item" id="gulf_of_mexico_nw">Gulf of Mexico</a>
<a role="menuitem" href="channels/india-news.html?channel=6496" target="_self" class="dropdown-item" id="india_pakistan_news_nw">India/Pakistan News</a>
<a role="menuitem" href="channels/iraq-news.html?channel=19" target="_self" class="dropdown-item" id="iraq_news_nw">Iraq News</a>
<a title="" href="https://www.newswise.com/channels/by-location-news/7" target="_self" class="view-all" id="view_all_by_location_channels_nw">View all by Location Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
<a class="dropdown-item collapsed" id="meetings_grants_events_nw" data-toggle="collapse" aria-expanded="false" data-target="#nav-meeting-m" href="#!">Meetings, Grants, and Events <i class="material-icons">keyboard_arrow_right</i></a>
<div id="nav-meeting-m" class="fcollapse">
<a role="menuitem" href="channels/grant-funded-news.html?channel=6296" target="_self" class="dropdown-item" id="grant_funded_news_nw">Grant Funded News</a>
<a role="menuitem" href="channels/medical-meetings.html?channel=6297" target="_self" class="dropdown-item" id="medical_meetings_nw">Medical Meetings</a>
<a role="menuitem" href="channels/newswise-live-event-in-progress.html?channel=6331" target="_self" class="dropdown-item" id="newswise_live_event_in_progress_nw">Newswise Live - Event in Progress</a>
<a role="menuitem" href="channels/newswise-live-expert-spotlight.html?channel=6407" target="_self" class="dropdown-item" id="newswise_live_expert_spotlight_nw">Newswise Live - Expert Spotlight</a>
<a role="menuitem" href="channels/newswise-live-events.html?channel=6323" target="_self" class="dropdown-item" id="newswise_live_events_nw">Newswise Live - Events</a>
<a role="menuitem" href="channels/scientific-meetings.html?channel=6298" target="_self" class="dropdown-item" id="scientific_meetings_nw">Scientific Meetings</a>
<a title="" href="https://www.newswise.com/channels/meeting-grants-events/8" target="_self" class="view-all" id="view_all_meeting_grants_events_channels_nw">View all Meeting, Grants &amp; Events Channels <i class="material-icons">arrow_right_alt</i></a>
</div>
</div>
</li>
<li class="nav-item top">
<a class="nav-link mm collapsed" id="experts_nw" href="https://www.newswise.com/experts" data-toggle="collapse" data-target="#experts-dd-menu" aria-expanded="false">Experts <i class="material-icons">keyboard_arrow_right</i></a>
<div id="experts-dd-menu" class="collapse sub-menu menu-one-column caret-dd">
<a class="dropdown-item" id="expert_pitch_nw" href="list/expert-pitch.html">Expert Pitch</a>
<a class="dropdown-item" id="expert_query_nw" href="https://www.newswise.com/resources/expert-query">Expert Query</a>
<a class="dropdown-item" id="expert_directory_nw" href="https://www.newswise.com/users/expert-list/">Expert Directory</a>

</div>
</li>

<li class="nav-item top">
<a class="nav-link mm collapsed" id="newsrooms_nw" href="https://www.newswise.com/institutions/list" data-toggle="collapse" data-target="#newsrooms-dd-menu" aria-expanded="false">Newsrooms <i class="material-icons">keyboard_arrow_right</i></a>
<div id="newsrooms-dd-menu" class="collapse sub-menu menu-one-column caret-dd">
<a class="dropdown-item" id="search_newsrooms_institutions_nw" href="https://www.newswise.com/institutions/list">Search Newsrooms/Institutions</a>
</div>
</li>
<li class="nav-item top">
<a class="nav-link mm" id="journalists_nw" href="https://www.newswise.com/journalists">Journalists</a>
</li>
<li class="nav-item top">
<a class="nav-link mm" id="pricing_nw" href="https://www.newswise.com/pricing">Pricing</a>
</li>
<li class="nav-item menu-item top">
<a class="nav-link mm collapsed" id="about_nw" href="https://www.newswise.com/about" data-toggle="collapse" data-target="#about-dd-menu" aria-expanded="false">About <i class="material-icons">keyboard_arrow_right</i></a>
<div id="about-dd-menu" class="collapse sub-menu menu-one-column caret-dd">
<a class="dropdown-item" id="member_services_nw" href="https://www.newswise.com/memberservices">Member Services</a>
<a class="dropdown-item" id="pricing_nw" href="https://www.newswise.com/pricing">Pricing</a>
<a class="dropdown-item" id="accessibility_statement_nw" href="https://www.newswise.com/accessibility">Accessibility Statement</a>
<a class="dropdown-item" id="newswise_live_nw" href="https://memberservices.newswise.com/fast-pitch/">Newswise Live</a>
<a class="dropdown-item" id="invoice_lookup_nw" href="https://payments.newswise.com/invoicelookup">Invoice Lookup</a>
<a class="dropdown-item" id="services_for_journalists_nw" href="https://www.newswise.com/journalists">Services for Journalists</a>
<a class="dropdown-item" id="archived_wires__nw" href="https://www.newswise.com/archive/wires/">Archived Wires</a>
<a class="dropdown-item" id="participating_institutions_nw" href="https://www.newswise.com/institutions/list">Participating Institutions</a>
<a class="dropdown-item" id="media_subscribers" href="https://www.newswise.com/media">Media Subscribers</a>
<a class="dropdown-item" id="sample_effectiveness_reports_nw" href="https://www.newswise.com/reports/demo">Sample Effectiveness Reports</a>
<a class="dropdown-item" id="terms_of_service_nw" href="https://www.newswise.com/terms-of-service">Terms of Service</a>
<a class="dropdown-item" id="privacy_policy_nw" href="https://www.newswise.com/privacy">Privacy Policy</a>
<a class="dropdown-item" id="our_staff_nw" href="https://www.newswise.com/newswise-staff">Our Staff</a>
<a class="dropdown-item" id="contact_newswise_nw" href="https://www.newswise.com/home/contact">Contact Newswise</a>
</div>
</li>
<li class="nav-item menu-item top">
<a class="nav-link mm collapsed" id="blog_nw" href="https://www.newswise.com/ee/list/">Blog</a>
<a class="dropdown-item" id="faq_nw" href="https://www.newswise.com/ee/faq/C1">FAQ</a>
<a class="dropdown-item" id="help_nw" href="https://www.newswise.com/home/contact">Help</a>
</li>
</ul>
</div>
</div>




<script data-cfasync="false" src="https://www.newswise.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/js/bootstrap.bundle.min.js" integrity="sha384-ka7Sk0Gln4gmtz2MlQnikT1wXgYsOg+OMhuP+IlRH9sENBO0LRn5q+8nbTov4+1p" crossorigin="anonymous"></script>

<script src="https://cdn.jsdelivr.net/npm/vanilla-lazyload@17.8.3/dist/lazyload.min.js"></script>
<script src="https://www.newswise.com/assets/newTheme/js/plugins.js"></script>
<script src="https://www.newswise.com/assets/newTheme/js/main.js"></script>




<link href="https://cdn.jsdelivr.net/npm/gijgo@1.9.6/css/gijgo.min.css" rel="stylesheet" type="text/css" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/select2/4.0.3/css/select2.min.css" rel="stylesheet" />
<script src="https://cdnjs.cloudflare.com/ajax/libs/select2/4.0.3/js/select2.min.js"></script>












<script src="https://www.newswise.com/assets/new/js/popper.min.js"></script>
<script src="https://www.newswise.com/assets/new/js/bootstrap.min.js"></script>
<script type="text/javascript" src="https://www.newswise.com/assets/new/plugins/bootstrap-filter-lightbox-gallery/js/glightbox.min.js"></script>
<script type="text/javascript" src="https://rawcdn.githack.com/nextapps-de/spotlight/0.6.3/dist/spotlight.cdn.js"></script>
<script type="text/javascript" src="https://www.newswise.com/assets/new/plugins/bootstrap-filter-lightbox-gallery/js/index.js"></script>
<script defer type="text/javascript" src="http://s7.addthis.com/js/300/addthis_widget.js#pubid=srice"></script>
<script defer src='http://js.trendmd.com/trendmd.min.js' data-trendmdconfig='{"journal_id":"61748","element":"#trendmd-suggestions"}'></script>
<script type="text/javascript">
			jQuery(document).ready(function($){
				/*jquery code to load related articles and library sections to articles view page begins*/
				$('#home_sections').load('/library/view-options');
				/*jquery code to load related articles and library sections to articles view page begins*/
				//$('#dummy_popular').load('/legacy/alerts/popular.html');
				$('[data-toggle="tooltip"]').tooltip();
			});
		</script>

<script>	
	jQuery.browser={};
	(function(){
		jQuery.browser.msie=false; 
		jQuery.browser.version=0;
		if(navigator.userAgent.match(/MSIE ([0-9]+)./)){ 
			jQuery.browser.msie=true;
			jQuery.browser.version=RegExp.$1;
		}
	})();	
	</script>
<script type="text/javascript" src="https://www.newswise.com/cdn/?&amp;jquery/singlepage/articleDetail&amp;mediaelement/2.13.1/mediaelement-and-player.min&amp;newswise/articles/gallery&amp;jquery.bxslider&amp;jquery.colorbox"></script>

<noscript><img src="https://certify.alexametrics.com/atrk.gif?account=UeW4n1aMp410N8" style="display:none" height="1" width="1" alt="Newswise Alexa Metrics" /></noscript>



<div style="background: #000;color: #fefefe;">0.10505</div>
<script>
var TxtType = function(el, toRotate, period) {
        this.toRotate = toRotate;
        this.el = el;
        this.loopNum = 0;
        this.period = parseInt(period, 10) || 2000;
        this.txt = '';
        this.tick();
        this.isDeleting = false;
    };

    TxtType.prototype.tick = function() {
        var i = this.loopNum % this.toRotate.length;
        var fullTxt = this.toRotate[i];

        if (this.isDeleting) {
        this.txt = fullTxt.substring(0, this.txt.length - 1);
        } else {
        this.txt = fullTxt.substring(0, this.txt.length + 1);
        }

        this.el.innerHTML = '<span class="wrap">'+this.txt+'</span>';

        var that = this;
        var delta = 200 - Math.random() * 100;

        if (this.isDeleting) { delta /= 2; }

        if (!this.isDeleting && this.txt === fullTxt) {
        delta = this.period;
        this.isDeleting = true;
        } else if (this.isDeleting && this.txt === '') {
        this.isDeleting = false;
        this.loopNum++;
        delta = 500;
        }

        setTimeout(function() {
        that.tick();
        }, delta);
    };

    window.onload = function() {
        var elements = document.getElementsByClassName('typewrite');
        for (var i=0; i<elements.length; i++) {
            var toRotate = elements[i].getAttribute('data-type');
            var period = elements[i].getAttribute('data-period');
            if (toRotate) {
              new TxtType(elements[i], JSON.parse(toRotate), period);
            }
        }
        // INJECT CSS
        var css = document.createElement("style");
        css.type = "text/css";
        css.innerHTML = ".typewrite > .wrap { border-right: 0.08em solid #fff}";
        document.body.appendChild(css);
    };
	
	document.addEventListener("DOMContentLoaded", function() {
	var lazyloadImages = document.querySelectorAll("img.lazy");    
	var lazyloadThrottleTimeout;
	
	function lazyload () {
		if(lazyloadThrottleTimeout) {
		clearTimeout(lazyloadThrottleTimeout);
		}    
		
		lazyloadThrottleTimeout = setTimeout(function() {
			var scrollTop = window.pageYOffset;
			lazyloadImages.forEach(function(img) {
				if(img.offsetTop < (window.innerHeight + scrollTop)) {
				img.src = img.dataset.src;
				img.classList.remove('lazy');
				}
			});
			if(lazyloadImages.length == 0) { 
			document.removeEventListener("scroll", lazyload);
			window.removeEventListener("resize", lazyload);
			window.removeEventListener("orientationChange", lazyload);
			}
		}, 20);
	}
	
	$(document).ready(function(){lazyload();})
	window.addEventListener("resize", lazyload);
	window.addEventListener("orientationChange", lazyload);
	});
</script>
<script defer src='https://static.cloudflareinsights.com/beacon.min.js' data-cf-beacon='{"token": "7652f610dc7b4ccca05c90a59c214310"}'></script>
<script>
 $('.has-sub a').click(function (e) {
        e.stopPropagation();
    });
</script>
<script defer src="https://static.cloudflareinsights.com/beacon.min.js/v52afc6f149f6479b8c77fa569edb01181681764108816" integrity="sha512-jGCTpDpBAYDGNYR5ztKt4BQPGef1P0giN6ZGVUi835kFF88FOmmn8jBQWNgrNd8g/Yu421NdgWhwQoaOPFflDw==" data-cf-beacon='{"rayId":"7c53fec62c8d458e","version":"2023.4.0","b":1,"token":"d0b4a4b67c2e4b09be15b32b5e7dca38","si":100}' crossorigin="anonymous"></script>
</body>

<!-- Mirrored from www.newswise.com/articles/first-patients-dosed-in-phase-2-platform-clinical-trial-testing-novel-immunotherapy-combinations-in-highly-malignant-ovarian-cancer by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 11 May 2023 10:23:22 GMT -->
</html>
